Source: Annual Congress 2002 - Current issues in lung transplantation
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. C. Riise, L. Berg, T. Bergstrom, S. Olofsson, K. Karre, E. Carbone (Gothenburg, Stockholm, Sweden). Increased LIR-1 expression precedes serum cytomegalovirus detection and diagnosis of CMV disease in lung transplant recipients. Eur Respir J 2002; 20: Suppl. 38, 2153

Member's Comments

No comment yet.

Related content which might interest you: Effective prevention of human cytomegalovirus (HCMV) disease in lung transplant recipients (LTR) by pre-emptive therapy based on HCMV monitoring in blood and lung Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019 CMV management in lung transplant recipients Source: School Course 2012 - Lung Transplantation Year: 2012 T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients Source: Eur Respir J 2006; 28: Suppl. 50, 344s Year: 2006 Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems Year: 2009 The frequency of cytomegalovirus infection detecting of patients with lung diseases Source: Eur Respir J 2006; 28: Suppl. 50, 153s Year: 2006 EBV and CMV as possible pathogens in patients presenting with interstitial lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 154s Year: 2006 Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays Source: Eur Respir J 2007; 30: Suppl. 51, 752s Year: 2007 Human lung transplantation: cytomegaloviral and rhinoviral co-infection is a distinct risk for acute rejection Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings Year: 2009 Cytomegalovirus quantitative-PCR study in pulmonary tissue from lung transplant recipients Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 Cytomegalovirus (CMV) infection – Correlation between CMV-DNA PCR in bronchoalveolar lavage (BAL), CMV pp65 antigen load in PBMCs and clinical symptoms in lung transplant recipients Source: Annual Congress 2011 - Improving outcomes after lung transplantation Year: 2011 Cytomegalovirus infection in lung transplant patients: the role of prophylaxis and recipient-donor serotype matching Source: Eur Respir J 2005; 26: Suppl. 49, 636s Year: 2005 The role of cytomegalovirus infection in the course of the lung diseases in children Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005 Prolonged oral ganciclovir (GCV) reduces the incidence of CMV infection and disease after lung transplantation (LTx) Source: Eur Respir J 2006; 28: Suppl. 50, 777s Year: 2006 Incidence of viral infections in patients with lung transplantation Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 Expression of EGR in lung transplant recipients Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 Longitudinal assessment of CD4+CD25highCD69- treg cells in a cohort of lung transplant recipients (LTR). An association with chronic graft rejection Source: Annual Congress 2008 - Donor organs and complications after lung transplantation Year: 2008 Basiliximab induction reduces the incidence of acute rejection in lung transplant patients Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 KL-6 in serum as a biomarker for differentiation of chronic allograft dysfuntion in lung transplant. Preliminary results Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Evaluation of IP-10 in blood serum for TB diagnosis in patients with late-stage HIV infection Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019